Feds Allege Ranbaxy Lied About Quality of Drugs

WASHINGTON (AP) - Federal prosecutors allege that Indian generic drugmaker Ranbaxy Laboratories deliberately misled the U.S. government about the quality of its low-cost medicines. The Justice Department is demanding Ranbaxy turn over documents which it hopes will prove the company fabricated data to convince the U.S. government to approve its products. Prosecutors made the allegations in a motion filed July 3 with the U.S. District Court of Maryland. The filing asks the court to order...Full Story
Commenting on this article is closed.